New Research on Canine Aging: What Longevity Studies Tell Us

When I was a child, a 10-year-old dog was considered ancient. Today, my neighbor’s Australian Shepherd just celebrated her 15th birthday with a veterinary checkup that showed normal organ function, clear eyes, and no arthritis. Something has changed—not just in veterinary care, but in our understanding of what canine aging actually is and how we might slow it down.

The Dog Aging Project: A Game-Changer

Launched in 2019, the Dog Aging Project is the largest longitudinal study of canine aging ever conducted. Led by researchers at the University of Washington and Texas A&M, it has enrolled over 45,000 dogs and aims to understand the biological, environmental, and genetic factors that influence aging. The project’s central hypothesis is that dogs, like humans, show significant variation in aging rates—and that some of this variation is modifiable.

Early findings from the project have been published in several high-impact journals. A 2023 Cell paper identified that larger dogs age faster than smaller dogs at the cellular level, not just chronologically. The mechanism appears to be related to insulin-like growth factor-1 (IGF-1), which is elevated in large breeds and accelerates cellular senescence. This explains the well-known paradox that small dogs live longer than large dogs despite being the same species.

Calorie Restriction: The Most Proven Intervention

The most robust evidence for lifespan extension in dogs comes from calorie restriction studies. The landmark Purina study, published in 2002 and still referenced today, followed 48 Labrador Retrievers for 14 years. One group was fed ad libitum (as much as they wanted). The other was fed 25% fewer calories. The calorie-restricted dogs lived an average of 1.8 years longer—15% longer than their well-fed counterparts. They also showed delayed onset of osteoarthritis, diabetes, and kidney disease.

A more recent 2023 follow-up at the University of Liverpool confirmed these findings in a larger, more diverse population of dogs. The mechanism appears to be reduced oxidative stress and improved mitochondrial function. Restricted-calorie dogs had lower levels of inflammatory markers (C-reactive protein, IL-6) and better glucose tolerance. The key caveat: the calorie restriction must be implemented before middle age. Starting restriction in senior dogs produced no significant lifespan benefit.

Rapamycin: The Anti-Aging Drug Being Tested

Rapamycin, an immunosuppressant used in organ transplant patients, has shown remarkable anti-aging properties in mice, extending lifespan by up to 30%. The Dog Aging Project is currently running a randomized controlled trial of low-dose rapamycin in middle-aged dogs. Results are preliminary, but the safety data is promising—no significant adverse effects at the tested doses (0.1-0.3 mg/kg three times weekly). Whether it extends lifespan in dogs won’t be known for several years, but the trial represents a historic first attempt to pharmacologically slow aging in companion animals.

Key Takeaways

• The Dog Aging Project has enrolled 45,000+ dogs and is the largest study of canine aging ever conducted
• Large dogs age faster than small dogs due to elevated IGF-1 levels
• Calorie restriction (25% fewer calories) extends lifespan by 1.8 years in dogs
• Rapamycin is being tested as the first anti-aging drug for dogs; safety data is promising
• Weight management before middle age is the single most impactful longevity intervention